Association of endotoxemia with carotid atherosclerosis and cardiovascular disease
Prospective results from the bruneck study
Christian J. Wiedermann, MD*,
Stefan Kiechl, MD ,
Stefan Dunzendorfer, MD*,
Peter Schratzberger, MD*,
Georg Egger, MD ,
Friedrich Oberhollenzer, MD and
Johann Willeit, MD
* Department of Internal Medicine, Medical Faculty, University of Innsbruck, Innsbruck, Austria
Department of Neurology, Medical Faculty, University of Innsbruck, Innsbruck, Austria
Department of Internal Medicine, Federal Hospital, Bruneck, Italy

View larger version (14K):
[in a new window]
|
Figure 1 Frequency distribution of endotoxin levels (pg/ml) (n = 516).
|
|

View larger version (30K):
[in a new window]
|
Figure 2 Binary-type association between endotoxin plasma level and atherosclerosis risk. OR = odds ratio; AS = atherosclerosis.
|
|

View larger version (51K):
[in a new window]
|
Figure 3 Risk of incident carotid atherosclerosis associated with endotoxin levels >50 pg/ml in nonsmokers, ex-smokers, and current smokers. **p < 0.01 for effect modification; OR = odds ratio; AS = atherosclerosis.
|
|

View larger version (43K):
[in a new window]
|
Figure 4 Age- and gender-adjusted incidence of carotid atherosclerosis according to endotoxin level and smoking status. AS = atherosclerosis. **p < 0.01; n.s. = not significant (vs. nonsmokers with endotoxin 50 pg/ml).
|
|

View larger version (47K):
[in a new window]
|
Figure 5 Risk of incident carotid atherosclerosis associated with endotoxin levels >50 pg/ml according to smoking status and presence of infectious diseases. The p values were derived from multivariate logistic regression analysis (*p < 0.05; **p < 0.01). OR = odds ratio; AS = atherosclerosis.
|
|
|